K Holli

3.9k total citations
47 papers, 3.0k citations indexed

About

K Holli is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, K Holli has authored 47 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 23 papers in Cancer Research and 17 papers in Genetics. Recurrent topics in K Holli's work include Breast Cancer Treatment Studies (22 papers), Global Cancer Incidence and Screening (10 papers) and BRCA gene mutations in cancer (8 papers). K Holli is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), Global Cancer Incidence and Screening (10 papers) and BRCA gene mutations in cancer (8 papers). K Holli collaborates with scholars based in Finland, United Kingdom and Sweden. K Holli's co-authors include Jorma Isola, J Isola, Olli Kallioniemi, Tuula Kuukasjärvi, Juha Kononen, Tapio Visakorpi, Jack Cuzick, Matti Hakama, Heikki Joensuu and Heikki Helin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

K Holli

47 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Holli Finland 28 1.8k 1.3k 778 772 468 47 3.0k
M. Bontenbal Netherlands 31 2.1k 1.2× 1.2k 0.9× 575 0.7× 667 0.9× 299 0.6× 66 3.4k
Giuseppe D’Aiuto Italy 28 1.4k 0.8× 1.2k 0.9× 697 0.9× 533 0.7× 334 0.7× 90 2.8k
Kaija Holli Finland 26 1.7k 1.0× 1.3k 0.9× 1.1k 1.4× 1.3k 1.7× 537 1.1× 54 3.3k
Eduardo R. Pajon United States 15 1.9k 1.1× 1.8k 1.3× 407 0.5× 929 1.2× 729 1.6× 22 3.4k
Rosalba Torrisi Italy 35 2.4k 1.3× 1.9k 1.4× 1.0k 1.3× 724 0.9× 643 1.4× 130 4.2k
Pierre O. Chappuis Switzerland 31 1.7k 1.0× 1.5k 1.1× 1.3k 1.7× 1.4k 1.8× 702 1.5× 107 3.6k
J Cuzick United Kingdom 7 2.0k 1.1× 2.0k 1.5× 565 0.7× 1.6k 2.1× 515 1.1× 10 3.6k
Christine D. Berg United States 18 1.2k 0.7× 768 0.6× 422 0.5× 727 0.9× 367 0.8× 43 2.5k
H.T. Mouridsen Denmark 22 1.4k 0.8× 1.3k 1.0× 328 0.4× 634 0.8× 438 0.9× 49 2.5k
M. Namer France 29 2.4k 1.4× 1.4k 1.0× 562 0.7× 612 0.8× 302 0.6× 122 3.7k

Countries citing papers authored by K Holli

Since Specialization
Citations

This map shows the geographic impact of K Holli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Holli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Holli more than expected).

Fields of papers citing papers by K Holli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Holli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Holli. The network helps show where K Holli may publish in the future.

Co-authorship network of co-authors of K Holli

This figure shows the co-authorship network connecting the top 25 collaborators of K Holli. A scholar is included among the top collaborators of K Holli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Holli. K Holli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korhonen, Tarja, Tuula Kuukasjärvi, Heini Huhtala, et al.. (2013). The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients. The Breast. 22(6). 1119–1124. 63 indexed citations
2.
Cuzick, Jack, JF Forbes, Ivana Šestak, et al.. (2007). Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial. JNCI Journal of the National Cancer Institute. 99(4). 272–282. 371 indexed citations
3.
Hietanen, Päivi, et al.. (2006). A short communication course for physicians improves the quality of patient information in a clinical trial. Acta Oncologica. 46(1). 42–48. 46 indexed citations
4.
Pylkäs, Katri, Johanna Tommiska, Kirsi Syrjäkoski, et al.. (2006). Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer. Carcinogenesis. 28(5). 1040–1045. 23 indexed citations
5.
Asola, R., Heini Huhtala, & K Holli. (2006). Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Research and Treatment. 100(1). 77–82. 34 indexed citations
6.
Salminen, Leena, et al.. (2003). Ocular side‐effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow‐up study. Acta Ophthalmologica Scandinavica. 81(5). 495–499. 36 indexed citations
7.
Kokko, R., K Holli, & Matti Hakama. (2002). Ca 15-3 in the follow-up of localised breast cancer. European Journal of Cancer. 38(9). 1189–1193. 58 indexed citations
8.
Holli, K, Rauni Saaristo, Jorma Isola, Heikki Joensuu, & Matti Hakama. (2001). Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. British Journal of Cancer. 84(2). 164–169. 128 indexed citations
9.
Bloigu, Risto, et al.. (2001). c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease. European Journal of Cancer. 37(3). 347–354. 58 indexed citations
10.
Isola, J, Tero A.H. Järvinen, Minna Tanner, & K Holli. (2000). [HER-2/neu oncogene in the selection of treatment for breast cancer and as a target of immunotherapy].. PubMed. 116(15). 1538–46. 1 indexed citations
11.
Hietanen, Päivi, Arja R. Aro, K Holli, & Pilvikki Absetz. (2000). Information and communication in the context of a clinical trial. European Journal of Cancer. 36(16). 2096–2104. 64 indexed citations
12.
Saarenmaa, Irma, Tiina Salminen, K Holli, et al.. (1999). The visibility of cancer on earlier mammograms in a population-based screening programme. European Journal of Cancer. 35(7). 1118–1122. 27 indexed citations
13.
Holli, K, Rauni Saaristo, Jorma Isola, Marja Hyöty, & Matti Hakama. (1998). Effect of radiotherapy on the interpretation of routine follow-up mammography after conservative breast surgery: a randomized study. British Journal of Cancer. 78(4). 542–545. 13 indexed citations
14.
Holli, K & Jorma Isola. (1997). Effect of age on the survival of breast cancer patients. European Journal of Cancer. 33(3). 425–428. 65 indexed citations
15.
Kuukasjärvi, Tuula, Juha Kononen, Heikki Helin, K Holli, & Jorma Isola. (1996). Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.. Journal of Clinical Oncology. 14(9). 2584–2589. 274 indexed citations
16.
Holli, K, J Isola, & M Hakama. (1995). Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - fact or fallacy. British Journal of Cancer. 71(1). 124–127. 20 indexed citations
17.
Isola, Jorma, Stephen Weitz, Tapio Visakorpi, et al.. (1993). Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.. Journal of Clinical Oncology. 11(1). 36–43. 100 indexed citations
18.
Isola, J, Tapio Visakorpi, K Holli, & Olli Kallioniemi. (1992). Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 84(14). 1109–1114. 312 indexed citations
19.
Blanco, Guillermo, K Holli, Mirja Heikkinen, Olli Kallioniemi, & Pentti J. Taskinen. (1990). Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. British Journal of Cancer. 62(1). 142–146. 67 indexed citations
20.
Holli, K & M Hakama. (1989). Treatment of the terminal stages of breast cancer.. BMJ. 298(6665). 13–14. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Bontenbal Breakdown of academic impact, for papers by Giuseppe D’Aiuto Breakdown of academic impact, for papers by Kaija Holli Breakdown of academic impact, for papers by Eduardo R. Pajon Breakdown of academic impact, for papers by Rosalba Torrisi Breakdown of academic impact, for papers by Pierre O. Chappuis Breakdown of academic impact, for papers by J Cuzick Breakdown of academic impact, for papers by Christine D. Berg Breakdown of academic impact, for papers by H.T. Mouridsen Breakdown of academic impact, for papers by M. Namer
Rankless by CCL
2026